Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis
- PMID: 22189356
- PMCID: PMC3330160
- DOI: 10.1038/gene.2011.82
Role of MYH9 and APOL1 in African and non-African populations with lupus nephritis
Abstract
Systemic lupus erythematosus (SLE) is a complex autoimmune disease characterized by autoantibody production and organ damage. Lupus nephritis (LN) is one of the most severe manifestations of SLE. Multiple studies reported associations between renal diseases and variants in the non-muscle myosin heavy chain 9 (MYH9) and the neighboring apolipoprotein L 1 (APOL1) genes. We evaluated 167 variants spanning MYH9 for association with LN in a multiethnic sample. The two previously identified risk variants in APOL1 were also tested for association with LN in European-Americans (EAs) (N = 579) and African-Americans (AAs) (N = 407). Multiple peaks of association exceeding a Bonferroni corrected P-value of P < 2.03 × 10(-3) were observed between LN and MYH9 in EAs (N = 4620), with the most pronounced association at rs2157257 (P = 4.7 × 10(-4), odds ratio (OR) = 1.205). A modest effect with MYH9 was also detected in Gullah (rs8136069, P = 0.0019, OR = 2.304). No association between LN and MYH9 was found in AAs, Asians, Amerindians or Hispanics. This study provides the first investigation of MYH9 in LN in non-Africans and of APOL1 in LN in any population, and presents novel insight into the potential role of MYH9 in LN in EAs.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
Similar articles
-
Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.Am J Nephrol. 2015;42(2):99-106. doi: 10.1159/000439448. Epub 2015 Sep 8. Am J Nephrol. 2015. PMID: 26343748 Free PMC article.
-
MYH9 and APOL1 gene polymorphisms and the risk of CKD in patients with lupus nephritis from an admixture population.PLoS One. 2014 Mar 21;9(3):e87716. doi: 10.1371/journal.pone.0087716. eCollection 2014. PLoS One. 2014. PMID: 24658608 Free PMC article.
-
End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.Arthritis Rheumatol. 2014 Feb;66(2):390-6. doi: 10.1002/art.38220. Arthritis Rheumatol. 2014. PMID: 24504811 Free PMC article.
-
The apolipoprotein L1 (APOL1) gene and nondiabetic nephropathy in African Americans.J Am Soc Nephrol. 2010 Sep;21(9):1422-6. doi: 10.1681/ASN.2010070730. Epub 2010 Aug 5. J Am Soc Nephrol. 2010. PMID: 20688934 Free PMC article. Review.
-
APOL1 and nephropathy progression in populations of African ancestry.Semin Nephrol. 2013 Sep;33(5):425-32. doi: 10.1016/j.semnephrol.2013.07.004. Semin Nephrol. 2013. PMID: 24119848 Free PMC article. Review.
Cited by
-
Lupus Nephritis Biomarkers: A Critical Review.Int J Mol Sci. 2024 Jan 9;25(2):805. doi: 10.3390/ijms25020805. Int J Mol Sci. 2024. PMID: 38255879 Free PMC article. Review.
-
The macrocyclic lactone oxacyclododecindione reduces fibrosis progression.Front Pharmacol. 2023 Jun 13;14:1200164. doi: 10.3389/fphar.2023.1200164. eCollection 2023. Front Pharmacol. 2023. PMID: 37383717 Free PMC article.
-
Evaluation of serum C4d levels in patients with systemic lupus erythematosus and its relation to lupus nephritis.Caspian J Intern Med. 2023 Spring;14(2):231-236. doi: 10.22088/cjim.14.2.231. Caspian J Intern Med. 2023. PMID: 37223281 Free PMC article.
-
Lupus Nephritis: Current Perspectives and Moving Forward.J Inflamm Res. 2022 Dec 2;15:6533-6552. doi: 10.2147/JIR.S363722. eCollection 2022. J Inflamm Res. 2022. PMID: 36483271 Free PMC article. Review.
-
Transcriptome Studies in Lupus Nephritis.Arch Immunol Ther Exp (Warsz). 2022 Apr 25;70(1):15. doi: 10.1007/s00005-022-00651-y. Arch Immunol Ther Exp (Warsz). 2022. PMID: 35469108 Review.
References
-
- Bae SC, Fraser P, Liang MH. The epidemiology of systemic lupus erythematosus in populations of African ancestry: a critical review of the "prevalence gradient hypothesis". Arthritis Rheum. 1998;41(112):2091–2099. - PubMed
-
- Serdula MK, Rhoads GG. Frequency of systemic lupus erythematosus in different ethnic groups in Hawaii. Arthritis Rheum. 1979;22(4):328–333. - PubMed
-
- Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25(11):1271–1277. - PubMed
-
- Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40(9):1725. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- P30 AR055385/AR/NIAMS NIH HHS/United States
- UL1 RR025005/RR/NCRR NIH HHS/United States
- UL1 RR025741/RR/NCRR NIH HHS/United States
- R01 DE018209-01A1/DE/NIDCR NIH HHS/United States
- P60 AR053308/AR/NIAMS NIH HHS/United States
- N01AR62277/AR/NIAMS NIH HHS/United States
- R01 AI063274/AI/NIAID NIH HHS/United States
- M01 RR000079/RR/NCRR NIH HHS/United States
- R01 AR043274-11/AR/NIAMS NIH HHS/United States
- R01 DE018209/DE/NIDCR NIH HHS/United States
- N01AI50026/AI/NIAID NIH HHS/United States
- RC1 AR058621-01/AR/NIAMS NIH HHS/United States
- P01 AR49084/AR/NIAMS NIH HHS/United States
- P20 RR020143/RR/NCRR NIH HHS/United States
- U19 AI082714/AI/NIAID NIH HHS/United States
- P30 GM103510/GM/NIGMS NIH HHS/United States
- R01 DK070941/DK/NIDDK NIH HHS/United States
- P60-2 AR30692/AR/NIAMS NIH HHS/United States
- UL1RR025741/RR/NCRR NIH HHS/United States
- P60 AR053308-01/AR/NIAMS NIH HHS/United States
- R01 AR043727-03/AR/NIAMS NIH HHS/United States
- UL1 RR024999/RR/NCRR NIH HHS/United States
- RC1 AR058554/AR/NIAMS NIH HHS/United States
- P30 AR053483/AR/NIAMS NIH HHS/United States
- M01 RR-00079/RR/NCRR NIH HHS/United States
- K08 AI083790/AI/NIAID NIH HHS/United States
- P30 AR048311-01/AR/NIAMS NIH HHS/United States
- UL1 TR000154/TR/NCATS NIH HHS/United States
- R01 AR033062-17/AR/NIAMS NIH HHS/United States
- P20 RR015577/RR/NCRR NIH HHS/United States
- UL1 RR025741-01/RR/NCRR NIH HHS/United States
- P30 RR031152/RR/NCRR NIH HHS/United States
- P20 RR015577-08/RR/NCRR NIH HHS/United States
- P30 AR053483-05/AR/NIAMS NIH HHS/United States
- UL1 RR024131/RR/NCRR NIH HHS/United States
- RC1 AR05884/AR/NIAMS NIH HHS/United States
- R01 AR056360-01A1/AR/NIAMS NIH HHS/United States
- R01 AR042460-09/AR/NIAMS NIH HHS/United States
- N01 AR062277/AR/NIAMS NIH HHS/United States
- R01 AR056360/AR/NIAMS NIH HHS/United States
- P01 AR049084-01/AR/NIAMS NIH HHS/United States
- K08 AI083790-01/AI/NIAID NIH HHS/United States
- R01 AR043814-03/AR/NIAMS NIH HHS/United States
- RC1 AR058621/AR/NIAMS NIH HHS/United States
- P60 AR049459-01/AR/NIAMS NIH HHS/United States
- UL1 RR029882-01/RR/NCRR NIH HHS/United States
- P30 AR048311/AR/NIAMS NIH HHS/United States
- R01 AI063274-02/AI/NIAID NIH HHS/United States
- R01 AR043814/AR/NIAMS NIH HHS/United States
- P60 AR049459/AR/NIAMS NIH HHS/United States
- R37 AI024717/AI/NIAID NIH HHS/United States
- R01 AR042460/AR/NIAMS NIH HHS/United States
- R01 AR057172/AR/NIAMS NIH HHS/United States
- R01AR051545-01A2/AR/NIAMS NIH HHS/United States
- R01 AR033062/AR/NIAMS NIH HHS/United States
- R01CA141700/CA/NCI NIH HHS/United States
- P01 AI083194-01/AI/NIAID NIH HHS/United States
- UL1 RR025014/RR/NCRR NIH HHS/United States
- UL1 RR029882/RR/NCRR NIH HHS/United States
- L30 AI071651/AI/NIAID NIH HHS/United States
- R01 AR43814/AR/NIAMS NIH HHS/United States
- R01 AR043727/AR/NIAMS NIH HHS/United States
- P60 AR030692-16/AR/NIAMS NIH HHS/United States
- ARC_/Arthritis Research UK/United Kingdom
- R01 CA141700/CA/NCI NIH HHS/United States
- R37 24717/PHS HHS/United States
- UL1 RR025005-01/RR/NCRR NIH HHS/United States
- LRP AI071651/AI/NIAID NIH HHS/United States
- M01 RR000079-32/RR/NCRR NIH HHS/United States
- K24 AI078004/AI/NIAID NIH HHS/United States
- K24 AR002138/AR/NIAMS NIH HHS/United States
- WT_/Wellcome Trust/United Kingdom
- R01 AR055240/AR/NIAMS NIH HHS/United States
- P30 AR048311-07/AR/NIAMS NIH HHS/United States
- UL1 RR025014-02/RR/NCRR NIH HHS/United States
- R01 AR33062/AR/NIAMS NIH HHS/United States
- R21 AI070304/AI/NIAID NIH HHS/United States
- P01 AI083194/AI/NIAID NIH HHS/United States
- L30 AI071651-01/AI/NIAID NIH HHS/United States
- P60 AR030692/AR/NIAMS NIH HHS/United States
- P20 RR020143-01/RR/NCRR NIH HHS/United States
- RC1 AR058554-01/AR/NIAMS NIH HHS/United States
- R21 AI070304-01/AI/NIAID NIH HHS/United States
- UL1 RR024131-04/RR/NCRR NIH HHS/United States
- P01 AR049084/AR/NIAMS NIH HHS/United States
- U19 AI082714-01/AI/NIAID NIH HHS/United States
- R37 AI024717-21/AI/NIAID NIH HHS/United States
- ULI RR025014-02/RR/NCRR NIH HHS/United States
- R01 AR051545/AR/NIAMS NIH HHS/United States
- UL1 RR024999-01/RR/NCRR NIH HHS/United States
- K24 AR002138-01/AR/NIAMS NIH HHS/United States
- R01 AR043274/AR/NIAMS NIH HHS/United States
- P60 AR062755/AR/NIAMS NIH HHS/United States
- N01 AI050026/AI/NIAID NIH HHS/United States
- R01 CA141700-01/CA/NCI NIH HHS/United States
- R01 AR051545-01A2/AR/NIAMS NIH HHS/United States
- N01 AR62277/AR/NIAMS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous